Current report filing

Consolidated Statements of Cash Flows

v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income $ 930,228 $ 954,843 $ 759,872
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 647,102 566,972 521,484
Deferred income taxes, net (26,134) 1,508 9,153
Loss on extinguishment of debt 13,397 6,346 22,211
Provision for bad debts and inventory obsolescence 3,884 5,570 2,431
Gain on involuntary conversion of assets (4,152)    
Share-based compensation expense 95,055 115,983 87,039
Net foreign currency adjustments (1,934) (5,537)  
Changes in operating assets and liabilities:      
Accounts receivable, net (14,104) (15,886) 15,050
Inventories (6,155) (9,052) (17,129)
Prepaid expenses and other assets (74,295) (29,519) (22,714)
Accounts payable (58,635) 106,387 14,047
Accrued expenses and other liabilities (29,028) 114,953 55,791
Advance ticket sales 347,376 262,603 154,012
Net cash provided by operating activities 1,822,605 2,075,171 1,601,247
Cash flows from investing activities      
Additions to property and equipment, net (1,637,170) (1,566,796) (1,372,214)
Cash received on settlement of derivatives 289 64,796 2,346
Cash paid on settlement of derivatives (47,085) (1,719) (35,694)
Other 3,774 1,011 664
Net cash used in investing activities (1,680,192) (1,502,708) (1,404,898)
Cash flows from financing activities      
Repayments of long-term debt (3,806,732) (1,716,244) (1,916,885)
Proceeds from long-term debt 4,122,297 1,904,865 1,816,390
Proceeds from employee related plans 31,937 28,819 30,032
Net share settlement of restricted share units (20,939) (13,855) (6,342)
Purchases of treasury shares (349,860) (664,811)  
Early redemption premium (6,829) (5,154) (15,506)
Deferred financing fees (23,262) (118,422) (56,195)
Net cash used in financing activities (53,388) (584,802) (148,506)
Net increase (decrease) in cash and cash equivalents 89,025 (12,339) 47,843
Cash and cash equivalents at beginning of period 163,851 176,190 128,347
Cash and cash equivalents at end of period $ 252,876 $ 163,851 $ 176,190